FRA:XUP • FR0004163111
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GENFIT (XUP.DE).
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 26.566M -68.96% | 38.176M 43.70% | 70.939M 85.82% | 52.142M -26.50% | 48.637M -6.72% | 61.897M 27.26% | 59.873M -3.27% | 72.334M 20.81% | 120.18M 66.15% | 184.85M 53.81% | 243.74M 31.86% | 324.4M 33.09% | |
| EBITDA YoY % growth | -25.473M -172.80% | -25.007M 1.83% | 4.949M 119.79% | 1.734M -64.96% | -18.233M -1,151.47% | -9.308M 48.95% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -27.305M -184.67% | -26.661M 2.36% | 3.225M 112.10% | -17.707M -649.06% | -23.46M -32.49% | -4.828M 79.42% | -25.64M -431.06% | -5.93M 76.87% | 48.666M 920.69% | 57.56M 18.28% | 101.22M 75.85% | 147.43M 45.65% | |
| Operating Margin | -102.78% | -69.84% | 4.55% | -33.96% | -48.23% | -7.80% | -42.82% | -8.20% | 40.49% | 31.14% | 41.53% | 45.45% | |
| EPS YoY % growth | N/A 41.79% | N/A 79.37% | N/A 325.98% | -0.47 -229.07% | -0.70 -47.57% | -0.20 70.70% | -0.29 -44.60% | N/A | N/A | N/A | N/A | N/A |
All data in EUR
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | 0.02 103.06% |
| Revenue Q2Q % growth | 42.942M 340.88% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | 3.621M 112.94% |
All data in EUR
12 analysts have analysed XUP.DE and the average price target is 9.17 EUR. This implies a price increase of 7.85% is expected in the next year compared to the current price of 8.5.
GENFIT (XUP.DE) will report earnings on 2026-02-26, after the market close.
The consensus EPS estimate for the next earnings of GENFIT (XUP.DE) is 0.02 EUR and the consensus revenue estimate is 42.94M EUR.
The number of analysts covering GENFIT (XUP.DE) is 12.